Webster, Lucy, Groskreutz, Derek, Grinbergs-Saull, Anna, Howard, Rob, O’Brien, John T, Mountain, Gail, Banerjee, Sube, Woods, Bob, Perneczky, Robert, Lafortune, Louise, and others. (2017) Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations. Health Technology Assessment, 21 (26). ISSN 1366-5278. (doi:10.3310/hta21260) (KAR id:97753)
PDF
Publisher pdf
Language: English |
|
Download this file (PDF/6MB) |
|
Request a format suitable for use with assistive technology e.g. a screenreader | |
Official URL: https://doi.org/10.3310/hta21260 |
Abstract
There is currently no disease-modifying treatment available to halt or delay the progression of the disease pathology in dementia. An agreed core set of the best-available and most appropriate outcomes for disease modification would facilitate the design of trials and ensure consistency across disease modification trials, as well as making results comparable and meta-analysable in future trials.
Item Type: | Article |
---|---|
DOI/Identification number: | 10.3310/hta21260 |
Subjects: | R Medicine |
Divisions: | Divisions > Division for the Study of Law, Society and Social Justice > School of Social Policy, Sociology and Social Research > Centre for Health Services Studies |
Depositing User: | Lucy Webster |
Date Deposited: | 02 Nov 2022 13:23 UTC |
Last Modified: | 03 Nov 2022 15:09 UTC |
Resource URI: | https://kar.kent.ac.uk/id/eprint/97753 (The current URI for this page, for reference purposes) |
- Link to SensusAccess
- Export to:
- RefWorks
- EPrints3 XML
- BibTeX
- CSV
- Depositors only (login required):